Who is eligible for clinical trial NCT06541002?

Participants must meet protocol criteria for Sexual Dysfunction. Confirm exact inclusion and exclusion requirements with the study coordinator.

Does clinical trial NCT06541002 provide travel or cost reimbursement?

Check with the site coordinator at the participating facility for travel and lodging stipend availability, and for which routine-care costs are covered.

🏛️ Verified NIH Record • Updated 2026-03-17

A Novel Digital Application (SHIFT) to Improve Outcomes for Hematopoietic Stem Cell Transplant Survivors (NCT06541002)

🟢 Recruiting Observational / Diagnostic 🧠 Behavioral & Psychological Program Sponsor: Massachusetts General Hospital

🩺 Plain-English Summary (8th-Grade Level)

This research study is evaluating the efficacy of a novel self-administered digital application for improving sexual health outcomes, quality of life, and psychological distress in hematopoietic stem cell transplant survivors.

Who can join: To join this study, participants generally need to meet the listed inclusion criteria (2 items) and avoid the listed exclusions (4 items).

Location: University of Miami — Coral Gables, Florida

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Check every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).

Adult patients (\> 18 years) who underwent autologous or allogeneic HCT \> three months prior to study enrollment
Screen positive for sexual health concerns causing distress based on the National Comprehensive Network (NCCN) survivorship guidelines screening questions

Usually NOT eligible if any of the following apply:

Exclusion Criteria:
Patients who do not comprehend English or Spanish since SHIFT will only be available in these two languages for this efficacy trial.
Patients with any major uncontrolled psychiatric disorder or other comorbid cognitive conditions, which the treating HCT clinician believes would prohibit the patients' capacity to provide informed consent and participate in study procedures.
Patients with relapsed disease requiring treatment.

🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.

📍 All Participating Trial Locations (3 Sites)

University of Miami — Coral Gables, Florida
Massachusetts General Hospital (MGH) — Boston, Massachusetts
Fox Chase Cancer Center — Philadelphia, Pennsylvania

💰 Cost, Insurance & Patient Rights

100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

🏛️ View Official NIH Record ↗